By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Carbapenems / beta-lactamase inhibitors > Imipenem, cilastatin, and relebactam
Carbapenems / beta-lactamase inhibitors

Imipenem, cilastatin, and relebactam

https://themeditary.com/drug/imipenem-cilastatin-and-relebactam-6255.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Aug 13, 2023  Additional Content by TheMediTary.Com

Generic name: imipenem, cilastatin, and relebactam [ im-i-pen-em, sye-la-stat-in, rel-e-bak-tam ]

Drug class: Carbapenems / beta-lactamase inhibitors

Dosage form: intravenous powder for injection (1.25 g)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Recarbrio, Imipenem, cilastatin sodium, and relebactam (monograph)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Imipenem, cilastatin, and relebactam?

Imipenem, cilastatin, and relebactam is a combination medicine that is used to treat complicated infections of the urinary tract (bladder and kidneys) or infections within the stomach area (abdomen).

Imipenem, cilastatin, and relebactam is also used to treat pneumonia (a lung infection) caused by being in a hospital or using a ventilator.

imipenem, cilastatin, and relebactam is for use in adults who have few or no other treatment options.

Imipenem, cilastatin, and relebactam may also be used for purposes not listed in this medication guide.

Warnings

Diarrhea may be a sign of a new infection. Call your doctor if you have diarrhea that is watery or has blood in it.

How should I take Imipenem, cilastatin, and relebactam

This medicine is given as an infusion into a vein. A healthcare provider will give you this injection.

You should receive this medicine for the full prescribed length of time, even if your symptoms quickly improve. Skipping doses can increase your risk of infection that is resistant to medication.

Imipenem, cilastatin, and relebactam will not treat a viral infection such as the flu or a common cold.

Dosing information

Usual Adult Dose for Nosocomial Pneumonia:

1.25 g IV every 6 hours for 4 to 14 days

Uses: For the treatment of patients with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia due to susceptible Acinetobacter calcoaceticus-baumannii complex, Enterobacter cloacae, Escherichia coli, Haemophilus influenzae, Klebsiella aerogenes, K oxytoca, K pneumoniae, Pseudomonas aeruginosa, and Serratia marcescens

Usual Adult Dose for Pyelonephritis:

1.25 g IV every 6 hours for 4 to 14 days

Comments:
-Approval of this indication based on limited clinical safety and efficacy data for this drug.

Use: In patients with limited or no alternative treatment options, for the treatment of complicated urinary tract infections (including pyelonephritis) due to susceptible E cloacae, E coli, K aerogenes, K pneumoniae, and P aeruginosa

Usual Adult Dose for Urinary Tract Infection:

1.25 g IV every 6 hours for 4 to 14 days

Comments:
-Approval of this indication based on limited clinical safety and efficacy data for this drug.

Use: In patients with limited or no alternative treatment options, for the treatment of complicated urinary tract infections (including pyelonephritis) due to susceptible E cloacae, E coli, K aerogenes, K pneumoniae, and P aeruginosa

Usual Adult Dose for Intraabdominal Infection:

1.25 g IV every 6 hours for 4 to 14 days

Comments:
-Approval of this indication based on limited clinical safety and efficacy data for this drug.

Use: In patients with limited or no alternative treatment options, for the treatment of complicated intraabdominal infections due to susceptible Bacteroides caccae, B fragilis, B ovatus, B stercoris, B thetaiotaomicron, B uniformis, B vulgatus, Citrobacter freundii, E cloacae, E coli, Fusobacterium nucleatum, K aerogenes, K oxytoca, K pneumoniae, Parabacteroides distasonis, and P aeruginosa

Detailed Cilastatin / imipenem / relebactam dosage information
Imipenem, cilastatin, and relebactam Dosage information (more detail)

Before Taking

You should not be treated with imipenem, cilastatin, and relebactam if you are allergic to imipenem, cilastatin, or relebactam.

Tell your doctor if you have ever had:

  • a seizure;

  • a stroke; or

  • an allergic reaction to penicillin or other antibiotic medicines.

Tell your doctor if you are pregnant or breastfeeding.

What happens if I miss a dose?

If you receive imipenem, cilastatin, and relebactam in a clinical setting, you are not likely to miss a dose.

Call your doctor for instructions if your infusions are given at home and you miss a dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Imipenem, cilastatin, and relebactam?

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, call your doctor before using anti-diarrhea medicine.

Imipenem, cilastatin, and relebactam side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Imipenem, cilastatin, and relebactam may cause serious side effects. Call your doctor at once if you have:

  • tremors;

  • a seizure; or

  • severe stomach pain, diarrhea that is watery or bloody (even if it occurs months after your last dose).

Common side effects of imipenem, cilastatin, and relebactam may include:

  • increased blood pressure;

  • nausea, diarrhea, vomiting;

  • abnormal liver function tests;

  • fever;

  • headache; or

  • pain, bruising, swelling, or irritation where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Imipenem, cilastatin, and relebactam Side Effects

What other drugs will affect Imipenem, cilastatin, and relebactam?

Tell your doctor about all your other medicines, especially:

  • divalproex sodium;

  • ganciclovir; or

  • valproic acid.

This list is not complete. Other drugs may affect imipenem, cilastatin, and relebactam, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

More about Imipenem, cilastatin, and relebactam (Imipenem, cilastatin, and relebactam [ im-i-pen-em, sye-la-stat-in, rel-e-bak-tam ])

Dosage information
Imipenem, cilastatin, and relebactam Side Effects
During pregnancy
Drug images
Side effects
Drug class: Carbapenems / beta-lactamase inhibitors

Related treatment guides

Urinary Tract Infection
Intraabdominal Infection
Nosocomial Pneumonia
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by